GET /api/v0.1/hansard/entries/1336451/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"id": 1336451,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1336451/?format=api",
"text_counter": 608,
"type": "speech",
"speaker_name": "Seme, ODM",
"speaker_title": "Hon. (Dr) James Nyikal",
"speaker": null,
"content": " My amendment on Clause 22 is very simple. It is just a cross reference. If you look at 22(3), which is saying, “(i) shall not apply to the sale of medicines compounded by pharmaceutical technologies”, my amendment is it should be (1)(a). Why am I saying (1)(a)? If you are excluding (a)(b)(c)(d) from the regulation because they are being compounded, the only one you can exclude is (a) because when you compound a product, it is not registered. It is something you are making at the pharmacy as you are doing it. That substance cannot be registered. However, (b)(c) and (d) should still apply, because those qualities are still required, whether you are compounding in pharmacy or it is coming registered. That is why I am saying instead of (1), we should say (1)(a)."
}